NCT06649071

Brief Summary

This is an observational study to explore the etiology and clinical classification in patients with obesity and to achieve personalized treatment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
29mo left

Started Oct 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Oct 2024Oct 2028

First Submitted

Initial submission to the registry

October 17, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 18, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

October 20, 2024

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2028

Last Updated

October 18, 2024

Status Verified

October 1, 2024

Enrollment Period

4 years

First QC Date

October 17, 2024

Last Update Submit

October 17, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Brain imaging features in patients with obesity by fMRI

    total brain volume, grey matter volume, white matter volume,cerebrospinal fluid volume, and nuclear bulk volume by MRI-derived normalized measures. All patients underwent odor-induced task fMRI on a 3.0T MR scanner with 222 volumes for task fMRI and 230 volumes for resting-state fMRI.

    From 2024 to 2028

  • Biomarkers of patients with obesity by blood sample

    Diagnostic biomarkers, predictive biomarkers, and prognostic biomarker in patients with obesity by blood sample

    From 2024 to 2028

  • Clinical classification of patients with obesity

    Based on the exploration of the unique brain imaging and biomarkers in patients with obesity, the clinical classification of obese patients was carried out.

    From 2024 to 2028

  • Prevention and intervention strategies for obesity based on clinical classification

    According to the clinical classification of obesity investigated in our previous study, personalized prevention and treatment strategies are designed to effectively slow down or reverse the obesity disease.

    From 2024 to 2028

Interventions

Naturalistic observation

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study is a dynamic prospective cohort study.

You may qualify if:

  • Patients with BMI≥28kg/m2
  • Aged 18-65 years of both sexes, right-handed
  • At least 6 years of education
  • Patients agreed and signed the informed consent

You may not qualify if:

  • Fewer than 6 years of education
  • Left-handedness
  • Dementia
  • Acute metabolic complications such as diabetic ketoacidosis
  • Hyperglycaemic hyperosmolar state and hypoglycaemic coma within the previous 3 months; history or presence of neurological or psychiatric disorders;
  • Presence of hypothyroidism;
  • History of malignancy, or severe kidney or liver dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

Nanjing, Jiangsu, 210008, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

DNA and mRNA

MeSH Terms

Conditions

Obesity

Interventions

Observational Studies as Topic

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Clinical Studies as TopicEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Yan Bi, M.D., Ph.D.

    Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
4 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Study Record Dates

First Submitted

October 17, 2024

First Posted

October 18, 2024

Study Start

October 20, 2024

Primary Completion (Estimated)

October 30, 2028

Study Completion (Estimated)

October 30, 2028

Last Updated

October 18, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations